{
    "medicine_id": "319290928961c06546b21c7a2b3585a9fc5eafce",
    "platform_id": "DB00210",
    "metadata": {
        "name": "Adapalene 1 mg 1g Gel",
        "composition": "1 mg 1g Adapalene",
        "clinical_particulars": {
            "therapeutic_indications": "Adapalene is indicated for the topical treatment of acne vulgaris in patients aged 12 and over L12873",
            "contraindications": {
                "disease": "Toxicity information regarding adapalene is not readily available Patients experiencing an overdose are at an increased risk of severe adverse effects such as redness scaling and skin discomfort Symptomatic and supportive measures are recommended L12873 Adapalene has an acute oral LD sub 50 sub in S D rats and CD 1 mice of over 5000 mg kg The LD sub 50 sub of 0 3 applied topically to Credo OF1 mice is over 10 ml kg 30 mg kg No systemic or local toxicity was observed in rats treated topically with 6 mg kg day of 0 3 adapalene L12897",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Adapalene is anticomedogenic preventing the formation of new comedones and inflammatory lesions and also acts to reduce inflammation by modulating the innate immune response A193512 Like other retinoid compounds adapalene is chemically stable but photosensitive use with sunscreen is recommended Minor skin irritations including erythema scaling dryness and stinging burning have been reported L12873",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of adverse effects can be increased when Salicylic acid is combined with Adapalene"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "The risk or severity of adverse effects can be increased when Resorcinol is combined with Adapalene"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}